Press Releases and News
We sat down over a virtual cup of coffee in August 2020 to interview Jason Lin, who has recently joined RedShiftBio as Senior Field Application Scientist. Editor: Hi Jason, welcome to the team! Can you tell us a bit about your background? What was your journey to working at RSB? JL: Spectroscopy has always been … “Applications Team Continues to Grow to Satisfy Demand”
Sean Veale Holly Lombardo We sat down over a virtual cup of coffee in July 2020 to interview Sean Veale and Holly Lombardo from the software team at RedShiftBio. Editor: Morning, thank you both for joining us today. Can you tell us a bit about your role at RedShiftBio? SV: I am the Director of … “Meet Members of the Software Team”
RedShift BioAnalytics, Inc. (RedShiftBio) announced its award winning AQS3pro, based on Microfluidic Modulation Spectroscopy (MMS) technology, is now available in Japan, following the appointment of Primetech as exclusive distributor.
We sat down over a virtual cup of coffee in May 2020 to interview Valerie Ivancic, who works on RedShiftBio’s applications team and has recently been awarded her PhD. Editor: Hi Valerie, thanks so much for joining us today. Congratulations on getting your PhD! VI: Thank you for having me. Editor: Can you tell us … “Meet Applications Specialist, Valerie Ivancic”
RedShift BioAnalytics, Inc. (RedShiftBio) announces its award winning AQS3pro, based on Microfluidic Modulation Spectroscopy (MMS) technology, is now available in China, following the appointment of Beijing-based Topbiox as exclusive distributor.
We sat down over a virtual cup of coffee in April 2020 to interview Allen Zhang, who has recently joined the growing sales team at RedShiftBio. Editor: Hi Allen, thanks so much for joining us today AZ: No problem! It is a pleasure to chat and have this opportunity to speak directly to our protein … “Meet Allen Zhang, the Latest Addition to our Expanding Team”
Pressure BioSciences, Inc., a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, and other industries, today announced that the combination of PBI’s patented Pressure Cycling Technology (“PCT”) with RedShiftBio’s proprietary Microfluidic Modulation Spectroscopy (“MMS”) resulted in a powerful new platform for biotherapeutic drug development (“PCT-enhanced MMS”).
RedShift BioAnalytics, Inc. (RedShiftBio), a provider of innovative analytical solutions for protein characterization used in biotherapeutic drug development, is pleased to announce the appointment of Julien Bradley as Chief Executive Officer.
Lisbon Portugal hosted the European PEGS conference. This is the largest European event covering all aspects of protein and antibody engineering. Over 1300 attendees gathered to learn about the latest advances in protein and antibody engineering. This was the second year we showcased the next generation IR-based AQS3pro for secondary structure characterization. During this conference … “The AQS³pro – A Hit For The Second Year Running at PEGS Europe”
The 2020 Well Characterized Biologics and Biological Assays conference has just concluded. The agenda focused on practical advice for ensuring CMC success using characterization strategies. Most attendees we spoke with were interested in exploring alternative technologies to circular dichroism and FTIR for monitoring protein structure changes. We demonstrated the power of IR-based Microfluidic Modulation Spectroscopy … “Accelerating Novel And Complex Modules Towards CMC Success”
